Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68788-4008

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68788-4008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin Calcium Tab Usp 10mg (Atorvastatin 10mg 90s Container Label)

Atorvastatin Calcium Tab Usp 10mg (Atorvastatin 10mg 90s Container Label)
This text is not readable.*
FDA Label Image

Atorvastatin-figure-01 (Atorvastatin Figure 01)

Atorvastatin-figure-01 (Atorvastatin Figure 01)
Cumulative incidence of Atorvastatin vs Placebo over 35 years, presented as percentages. The data shows a decrease in cumulative incidence over time, with Atorvastatin having a higher incidence compared to Placebo.*
FDA Label Image

Atorvastatin-figure-02 (Atorvastatin Figure 02)

Atorvastatin-figure-02 (Atorvastatin Figure 02)
This text includes information about the cumulative hazard percentage in a study involving a placebo group and a group taking Atorvastatin. It shows a Hazard Ratio of 0.63 with a corresponding confidence interval (0.48-0.83), and a p-value of 0.001. The data pertains to the time taken to reach the first primary endpoint over a four-year follow-up period.*
FDA Label Image

Atorvastatin-figure-03 (Atorvastatin Figure 03)

Atorvastatin-figure-03 (Atorvastatin Figure 03)
This text provides information about two dosages of Atorvastatin (10 mg and 80 mg) and their effects on reducing the risk of major cardiovascular events over time. The results show a significant reduction in risk with both dosages, as indicated by the hazard ratio (HR) of 0.78 (95% CI 0.69-0.89, p=0.0002) for Atorvastatin 10 mg. The study evaluates the time to the first major cardiovascular endpoint in years.*
FDA Label Image

Structure (Atorvastatin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.